• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

关于“静脉血栓栓塞症的新前沿”特刊的社论

Editorial on the Special Issue "The New Frontier of Venous Thromboembolism".

作者信息

Di Micco Pierpaolo, Imbalzano Egidio, Camporese Giuseppe

机构信息

AFO Medicina, UOC Medicina Interna, P.O. Santa Maria delle Grazie, ASL NA2 Nord, 80078 Pozzuoli, Italy.

Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.

出版信息

Life (Basel). 2023 Oct 17;13(10):2071. doi: 10.3390/life13102071.

DOI:10.3390/life13102071
PMID:37895452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10608283/
Abstract

In recent years, great efforts have been made to improve decision making in caring for patients of venous thromboembolism (VTE) [...].

摘要

近年来，为改善静脉血栓栓塞症（VTE）患者的护理决策已付出巨大努力。[...]

相似文献

1
Editorial on the Special Issue "The New Frontier of Venous Thromboembolism".关于“静脉血栓栓塞症的新前沿”特刊的社论
Life (Basel). 2023 Oct 17;13(10):2071. doi: 10.3390/life13102071.
2
[Up-to-date medical care for perioperative venous thromboembolism in Japan--standardization of care for perioperative venous thromboembolism in Japan: preface].[日本围手术期静脉血栓栓塞症的最新医疗——日本围手术期静脉血栓栓塞症护理的标准化：前言]
Masui. 2007 Jul;56(7):758-9.
3
Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis.在实施静脉血栓栓塞预防改善项目期间，一项静脉血栓栓塞预防改善项目对住院患者血栓栓塞发生率和出血率的影响。
Mayo Clin Proc Innov Qual Outcomes. 2020 Feb 17;4(2):159-169. doi: 10.1016/j.mayocpiqo.2019.10.006. eCollection 2020 Apr.
4
Use of decision aids for shared decision making in venous thromboembolism: A systematic review.使用决策辅助工具促进静脉血栓栓塞症的共同决策：系统评价。
Thromb Res. 2016 Jul;143:71-5. doi: 10.1016/j.thromres.2016.05.009. Epub 2016 May 12.
5
Sex and gender issues and venous thromboembolism.性别与静脉血栓栓塞问题
Clin Chest Med. 2004 Jun;25(2):281-97. doi: 10.1016/j.ccm.2004.01.013.
6
[Current Recommendations for the Prevention and Treatment of Venous Thromboembolism in Cancer Patients].[癌症患者静脉血栓栓塞预防与治疗的当前建议]
Klin Onkol. 2017 Spring;30(2):100-105. doi: 10.14735/amko2017100.
7
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).肺癌静脉血栓栓塞症和早期死亡率的预测因素：一项全球前瞻性研究（CANTARISK）的结果。
Oncologist. 2018 Feb;23(2):247-255. doi: 10.1634/theoncologist.2017-0205. Epub 2017 Sep 26.
8
Translating evidence-based guidelines into performance measures for venous thromboembolism and acute coronary syndrome.将基于证据的指南转化为静脉血栓栓塞症和急性冠状动脉综合征的绩效指标。
Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S25-9. doi: 10.2146/ajhp070110.
9
Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study.非危重症儿童医院获得性静脉血栓栓塞症新风险评分的开发：一项大型单机构病例对照研究的结果
J Pediatr. 2014 Oct;165(4):793-8. doi: 10.1016/j.jpeds.2014.05.053. Epub 2014 Jul 23.
10
Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register.静脉血栓栓塞症（VTE）后二级预防的治疗决策：来自真实世界 START2-POST-VTE 登记研究的数据。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620945792. doi: 10.1177/1076029620945792.

本文引用的文献

1
Catheter-Directed Interventions for the Treatment of Lower Extremity Deep Vein Thrombosis.导管定向介入治疗下肢深静脉血栓形成
Life (Basel). 2022 Nov 27;12(12):1984. doi: 10.3390/life12121984.
2
Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project.利伐沙班用于癌症合并静脉血栓栓塞症患者延长阶段抗凝治疗的安全性与有效性：来自Mac项目的初步数据分析
Life (Basel). 2022 Oct 28;12(11):1725. doi: 10.3390/life12111725.
3
Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project.利伐沙班用于不明原因或复发性静脉血栓栓塞症患者长期抗凝治疗的安全性和有效性：来自MAC项目的真实世界数据
Life (Basel). 2022 Oct 20;12(10):1657. doi: 10.3390/life12101657.
4
Multidisciplinary Care for the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer-Associated Thrombosis (CAT): Impact of Educational Interventions on CAT-Related Events and on Patients' and Clinicians' Awareness.癌症相关血栓形成（CAT）患者静脉血栓栓塞预防与治疗的多学科护理：教育干预对CAT相关事件以及患者和临床医生认知的影响
Life (Basel). 2022 Oct 13;12(10):1594. doi: 10.3390/life12101594.
5
Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.接受新辅助化疗和根治性膀胱切除术治疗肌层浸润性膀胱癌患者的中心静脉通路与血栓栓塞事件风险
Life (Basel). 2022 Aug 6;12(8):1198. doi: 10.3390/life12081198.
6
Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy.利伐沙班单药治疗肺栓塞患者：超说明书用药与说明书标注治疗
Life (Basel). 2022 Jul 27;12(8):1128. doi: 10.3390/life12081128.
7
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study.凝血酶原酶诱导凝血时间用于测定临床实践中利伐沙班、阿哌沙班和依度沙班的药物浓度：一项横断面研究。
Life (Basel). 2022 Jul 11;12(7):1027. doi: 10.3390/life12071027.
8
Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on "Two-Path Unifying Theory" of Hemostasis and "Two-Activation Theory of the Endothelium".深静脉血栓形成两面性的发病机制：基于止血“双途径统一理论”和内皮“双激活理论”，通过统一机制将静脉血栓栓塞重新定义为微血栓与大血栓的组合
Life (Basel). 2022 Jan 31;12(2):220. doi: 10.3390/life12020220.